All News
Filter News
Found 10,415 articles
-
Addrenex Pharmaceuticals' New Hires Further Company Goal to Identify New Drugs for Adrenergic Regulation
8/20/2008
-
Eli Lilly and Company Impotence Drug Treats Prostate Enlargement, University of Texas Southwestern Medical Center and Northwestern University Study
8/19/2008
-
Eli Lilly and Company, Amylin Pharmaceuticals, Inc. Diabetes Drug Linked to Two Deaths; FDA To Strengthen Warnings
8/19/2008
-
BioMS Medical Announces Positive Interim Analysis on Phase III Trial of Dirucotide (MBP8298) for Multiple Sclerosis
8/14/2008
-
SGX Pharmaceuticals, Inc. Release: Eli Lilly and Company Merger Offer Receives Positive Opinions From Proxy Advisory Firms
8/14/2008
-
Anthera Pharmaceuticals, Inc. Completes $19 Million Financing; Appoints Christopher S. Henney as Chairman
8/13/2008
-
BioMS Medical Announces Second Quarter 2008 Results
8/13/2008
-
EMC Receives Eli Lilly and Company Global Sustained Supplier Award
8/12/2008
-
i3 Statprobe Selected to Assume Bulk of Eli Lilly and Company's U.S. Data Management Work
8/8/2008
-
AutoImmune, Inc. Reports 2008 Second Quarter Financial Results
8/7/2008
-
Covance Inc. and Eli Lilly and Company (JOBS) Execute 10-Year, $1.6 Billion Services Contract; Covance to Acquire Lilly's Greenfield, Indiana Campus for $50 Million
8/6/2008
-
Phase Forward, Eli Lilly and Company Extend Multi-Year Agreement
8/6/2008
-
Eli Lilly and Company Won't Raise Buyout Offer for SGX Pharmaceuticals, Inc.
8/4/2008
-
BioMS Medical Completes Patient Recruitment in Phase III U.S. Multiple Sclerosis Trial
8/1/2008
-
Eli Lilly and Company (JOBS) Says Alzheimer's Antibody Drug Safe
7/31/2008
-
Artel Launches its Pipette Quality Management System for Rapid Implementation of Internal Pipette Calibration Programs
7/29/2008
-
Vanda Pharmaceuticals, Inc. Announces Receipt of Not Approvable Letter From FDA for Iloperidone
7/28/2008
-
Bristol-Myers Squibb Company (JOBS) Comes Out Swinging At Eli Lilly and Company (JOBS) Clot Drug
7/25/2008
-
Zelos Therapeutics Reaches Agreement with the FDA and EMEA for a Registration Study of ZT-031 for the Treatment of Osteoporosis
7/24/2008
-
Innovative Investment Relationship to Develop Eli Lilly and Company's Two Lead Alzheimer's Molecules
7/24/2008